Description: Our mission is to confirm or exclude Lynch syndrome. Our innovation simplifies early detection of Lynch syndrome, provides actionable results and can help prevent cancer.
Our Mission is to provide reliable Lynch syndrome diagnostics to empower families and healthcare professionals to make better informed decisions for cancer prevention.
1 in 279 people have Lynch syndrome, i.e. inherited mismatch repair (MMR) deficiency, making it the most common cause of hereditary cancers.
Lynch syndrome (LS) is inherited with 50% probability within affected families. Each single year, more than 2 million new cancer cases should be tested for LS.